(S)-2-hydroxybutane-1,4-diyl bis(4-methylbenzenesulfonate)

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-2-hydroxybutane-1,4-diyl bis(4-methylbenzenesulfonate)
• 英文别名: (R)-2-Hydroxybutane-1,4-diyl bis(4-methylbenzenesulfonate)；[(3S)-3-hydroxy-4-(4-methylphenyl)sulfonyloxybutyl] 4-methylbenzenesulfonate
• 化学式: C₁₈H₂₂O₇S₂
• 分子量: 414.5
• InChiKey: QFTXCKUWSDSERO-INIZCTEOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  27
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  124
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  (S)-2-hydroxybutane-1,4-diyl bis(4-methylbenzenesulfonate) 在 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 7.0h， 生成 (S)-4-甲基苯磺酰基氧基-1,2-环氧丁烷
  参考文献：
  名称：

  Enantiodivergent syntheses of (+)- and (-)-nonactic acid and the total synthesis of nonactin

  摘要：

  DOI：

  10.1021/ja00330a045
• 作为产物：
  描述：

  (2S,1'RS)-2-(1'-ethoxyethyloxy)-1,4-butanediyl bis(p-toluenesulfonate) 在 4-甲基苯磺酸吡啶 作用下， 以 甲醇 为溶剂， 反应 14.0h， 生成 (S)-2-hydroxybutane-1,4-diyl bis(4-methylbenzenesulfonate)
  参考文献：
  名称：

  Enantiodivergent syntheses of (+)- and (-)-nonactic acid and the total synthesis of nonactin

  摘要：

  DOI：

  10.1021/ja00330a045

文献信息

• Process for the preparation of oxazolidinones and method of use thereof
  申请人：Hollingsworth I. Rawle

  公开号：US20070265451A1

  公开（公告）日：2007-11-15

  A process for preparing N-(substituted)-C-(substituted methyl)-oxazolidinones, C-(substituted methyl)-oxazolidinones, and N-(substituted)-C-(substituted methyl)-oxazolidinones, preferably chiral, from optically active C-(protected oxymethyl)-oxazolidinones is described. The process can be used to produce combinatorial libraries of the above substituted oxazolidinones in a two or three step reaction comprising a plurality of reagents differing in numbers of carbons or particular substituted oxazolidinones. A number of substituted oxazolidinones produced using the above process have been discovered to have antimicrobial activity.

  本文介绍了一种从光学活性的C-（保护的氧甲基）-噁唑烷酮制备N-（取代）-C-（取代甲基）-噁唑烷酮、C-（取代甲基）-噁唑烷酮和N-（取代）-C-（取代甲基）-噁唑烷酮的方法，其中优选手性化合物。该方法可用于在包含多种碳数或特定取代噁唑烷酮的多种试剂的两步或三步反应中产生上述取代噁唑烷酮的组合库。使用上述方法生产的许多取代噁唑烷酮已被发现具有抗微生物活性。
• PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF
  申请人：Hollingsworth Rawle I.

  公开号：US20080146458A1

  公开（公告）日：2008-06-19

  Substituted oxazolidinone of the formula: wherein R 2 is alkyl selected from the group consisting of methyl, ethyl, and isopropyl moieties, are described. The compounds are antibacterial.

  描述了以下化学式的氧杂环丙酮类替代物：其中R2是选择自甲基，乙基和异丙基基团的烷基。这些化合物具有抗菌作用。
• SYNTHETIC PROCESS FOR AMINOCYCLOHEXYL ETHER COMPOUNDS
  申请人：Plouvier Bertrand M. C.

  公开号：US20100152464A1

  公开（公告）日：2010-06-17

  Methods for the preparation of stereoisomerically substantially aminocyclohexyl ether compounds such as trans-(1R,2R)-aminocyclohexyl ether compounds and/or trans-(1S,2S)-aminocyclohexyl ether compounds as well as various intermediates and substrates are disclosed.

  本发明揭示了制备立体异构的氨基环己基醚化合物的方法，例如trans-(1R,2R)-氨基环己基醚化合物和/或trans-(1S,2S)-氨基环己基醚化合物，以及各种中间体和底物。
• GLS1 INHIBITORS FOR TREATING DISEASE
  申请人：Board of Regents, The University of Texas System

  公开号：US20160009704A1

  公开（公告）日：2016-01-14

  Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

  本文揭示了一些化合物和组合物，其结构公式为I，可用于治疗GLS1介导的疾病，如癌症。还提供了抑制人类或动物主体中GLS1活性的方法。
• HETEROCYCLIC GLS1 INHIBITORS
  申请人：Board of Regents, The University of Texas System

  公开号：EP3677579A1

  公开（公告）日：2020-07-08

  Disclosed herein are compounds and compositions useful in the treatment of GLS I mediated diseases, such as cancer, having the structure of Formula I. Methods of inhibition GLS I activity in a human or animal subject are also provided.

  本文公开了用于治疗 GLS I 介导的疾病（如癌症）的具有式 I 结构的化合物和组合物。还提供了抑制人或动物体内 GLS I 活性的方法。